| The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111 … M Bond, G Rogers, J Peters, R Anderson, M Hoyle, A Miners, T Moxham, ... Health technology assessment (Winchester, England) 16 (21), 1-470, 2012 | 376 | 2012 |
| Temozolomide for high grade glioma MG Hart, R Garside, G Rogers, K Stein, R Grant The Cochrane Library, 2013 | 322 | 2013 |
| Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. J Thompson Coon, G Rogers, P Hewson, D Wright, R Anderson, M Cramp, ... Health technology assessment (Winchester, England) 11 (34), 1-206, 2007 | 268 | 2007 |
| The harmful health effects of recreational ecstasy: a systematic review of observational evidence. G Rogers, J Elston, R Garside, C Roome, RS Taylor, P Younger, ... NIHR Health Technology Assessment programme, 2009 | 204 | 2009 |
| Chemotherapy wafers for high grade glioma MG Hart, R Garside, G Rogers, M Somerville, K Stein, R Grant The Cochrane Library, 2011 | 184* | 2011 |
| Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis J Thompson Coon, G Rogers, P Hewson, D Wright, R Anderson, ... British journal of cancer 98 (7), 1166-1175, 2008 | 130 | 2008 |
| Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model C Hyde, J Peters, M Bond, G Rogers, M Hoyle, R Anderson, M Jeffreys, ... Age and Ageing, 2012 | 129 | 2012 |
| Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment … J Shepherd, G Rogers, R Anderson, C Main, J Thomson-Coon, D Hartwell Health Technology Assessment 12 (19), 1-360, 2008 | 125 | 2008 |
| The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic … R Garside, M Pitt, R Anderson, G Rogers, M Dyer, S Mealing, ... Health Technology Assessment (Winchester, England) 11 (45), iii-iv, ix, 2007 | 108 | 2007 |
| Parkinson’s disease: summary of updated NICE guidance G Rogers, D Davies, J Pink, P Cooper Bmj 358, 2017 | 101 | 2017 |
| Diagnosis and management of gallstone disease: summary of NICE guidance S Warttig, S Ward, G Rogers Bmj 349, 2014 | 99 | 2014 |
| Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness JS Thompson Coon, Z Liu, M Hoyle, G Rogers, C Green, T Moxham, ... British journal of cancer 101 (2), 238-243, 2009 | 66 | 2009 |
| Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease KA Anie, H Grocott, L White, M Dzingina, G Rogers, G Cho BMJ open 2 (4), e001274, 2012 | 56 | 2012 |
| Dasatinib and nilotinib for imatinib-resistant or-intolerant chronic myeloid leukaemia: a systematic review and economic evaluation G Rogers, M Hoyle, J Thompson-Coon, T Moxham, Z Liu, M Pitt, K Stein NIHR Health Technology Assessment Programme, 2012 | 47 | 2012 |
| Dasatinib and nilotinib for imatinib-resistant or-intolerant chronic myeloid leukaemia: a systematic review and economic evaluation G Rogers, M Hoyle, JT Coon, T Moxham, Z Liu, M Pitt, K Stein Health Technology Assessment 16 (22), 1366-5278, 2012 | 46 | 2012 |
| Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or-intolerant chronic phase chronic myeloid leukemia M Hoyle, G Rogers, T Moxham, Z Liu, K Stein Value in Health 14 (8), 1057-1067, 2011 | 43 | 2011 |
| Spondyloarthritis: diagnosis and management: summary of NICE guidance K McAllister, N Goodson, L Warburton, G Rogers Bmj 356, 2017 | 33 | 2017 |
| Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis G Rogers, R Garside, S Mealing, M Pitt, R Anderson, M Dyer, K Stein, ... PharmacoEconomics 26 (1), 33-44, 2008 | 24 | 2008 |
| Acute kidney injury: prevention, detection, and management. Summary of updated NICE guidance for adults receiving iodine-based contrast media T Barrett, A Khwaja, C Carmona, Y Martinez, H Nicholas, G Rogers, ... Clinical Radiology 76 (3), 193-199, 2021 | 14 | 2021 |
| The clinical-and cost-effectiveness of lenalidomide for multiple myeloma in people who have received at least one prior therapy: an evidence review of the submission from Celgene M Hoyle, G Rogers, R Garside, T Moxham, K Stein University of Exeter, 2008 | 11 | 2008 |
Ken SteinUniversity of ExeterVerified email at exeter.ac.uk
